FibroGen Inc is a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for serious unmet medical needs. With a strong pipeline of potential treatments targeting fibrosis, anemia, and cancer, FibroGen is poised to make a significant impact in the healthcare industry.
Notification